Latest Updates

Therapy targets gram-negative bacterial infections in critical care settings

Appointment to focus on private equity and M&A advisory in life sciences sector

Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections

Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; market size at US$ 145 million

The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform brought together FR&D leaders to discuss…

Former Cipla CEO to lead next phase for CDMO platform focused on complex chemistry and APIs

Five-year agreement focuses on open science access, joint research and capability building

Deal combines portfolios and expands presence across women’s health, biosimilars and global markets

Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceutical research collaboration

Company outlines expansion across multiple states and pipeline of formulations under development

Transaction to create integrated global biosimilars platform combining development, manufacturing and commercial capabilities

Platform to support workforce development for quality, production and regulatory roles

Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover…

Inspection cycle closed following February 2026 USFDA audit

Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University Mumbai, examines the complex legal and ethical…

USFDA approves ANDA for bioequivalent version of Xigduo XR

Investment brings board representation and expansion plans in ophthalmic segment

Partnership progresses ANDA filing for generic version of Ozempic with manufacturing support from OneSource

Krishna Sarma highlights the ecosystem requirements for advancing biopharma innovation in India

Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing engagements